SRZN experienced a catastrophic financial deterioration with net losses nearly tripling to $242M, stockholders' equity plunging to negative $187.8M, and revenue collapsing 67% despite a significant cash infusion.
The company appears to be in severe financial distress with massive cash burn accelerating and fundamental business performance deteriorating rapidly. While they raised substantial capital (evidenced by the cash increase to $89.2M), the dramatic increase in total liabilities to $286.5M and deeply negative equity position suggest potential solvency concerns that investors should monitor closely.
SRZN's financials show a company in crisis with net losses expanding 281% to $242M while revenue collapsed 67% to just $3.5M, indicating core business fundamentals are severely deteriorating. The company appears to have raised significant capital (cash increased 158% to $89.2M) but this was overwhelmed by a 310% surge in total liabilities to $286.5M, driving stockholders' equity to a deeply negative $187.8M. The overall picture signals potential solvency risk despite the recent capital raise, as operating cash flow losses widened 72% and the liability burden has grown dramatically.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Capital expenditure jumped 392.3% — major investment cycle underway; assess returns on deployment.
Liabilities grew 310.2% — significant increase in debt or obligations, assess impact on financial flexibility.
Net income declined 280.8% — review whether driven by operations, interest costs, or non-recurring items.
Cash position surged 158.2% — strong cash generation or capital raise providing significant financial cushion.
Current assets grew 135.2% — improving short-term liquidity or inventory/receivables build.
Asset base grew 103.7% — expansion through organic growth, acquisitions, or capital deployment.
Operating cash flow fell 71.6% — earnings quality concerns; investigate working capital changes and non-cash items.
Revenue declined 67.4% — significant demand weakness or market share loss warrants investigation.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →